Malignant Solid Tumor
A malignant solid tumor is a type of cancer that forms in solid organs or tissues, such as the lungs, breast, or colon, and can invade nearby tissues and spread to other parts of the body.
Advanced Solid Tumors and Blood Cancer: Durvalumab and Tremelimumab Study
We are testing the safety and early effectiveness of Durvalumab alone and with Tremelimumab in children with advanced solid tumors and blood cancers. This study aims to find the best dosage and understand how these treatments work.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 1 and 75 years old?
- Do you have a confirmed cancer diagnosis?
- Have you had any autoimmune diseases like lupus, rheumatoid arthritis, or inflammatory bowel disease?
- Have you had any major organ transplants, like a kidney or liver transplant?
- Have you had any active infections like tuberculosis, hepatitis B, hepatitis C, or HIV?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitari Vall D Hebron
Pediatric
Barcelona, Spain
Hospital Infantil Universitario Nino Jesus
Pediatric
Madrid, Spain
Sponsor: AstraZeneca AB
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.